4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006531
Chief Financial Officer sold 11,296 shares at $8.94 ($100,986)
- Chief Financial Officer acquired 229,421 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Joseph M Chief Financial Officer | 2023-03-02 | Grant or award | +229,421 | 342,510 | D | ||
| Miller Joseph M Chief Financial Officer | 2023-03-02 | Sale | −11,296 | $8.94 | $100,986 | 331,214 | D |
| Open-market sales · 11,296 sh · avg $8.94 · $100,986 | |||||||
Loading xslF345X03/wf-form4_167813814945028.xml…